Clinical Trials

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as...

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension (LTE) Phase 1b study...

ViiV Healthcare announced positive headline results from its global, phase III ATLAS study of a long-acting, injectable two-drug regimen (2DR)...

In a milestone transaction, a major pharmaceutical company based in China will undertake a multisite clinical study using TrialMaster EDC...

Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study...

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the...

An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that...

A pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat moderate-to-severe atopic dermatitis in adolescents (ages 12-17) met its primary...

Pfizer Inc. announced positive top-line results of a Phase 3 study examining the use of LYRICA® (pregabalin) Oral Solution CV...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the first positive Phase 1 clinical data assessing cemiplimab as a potential treatment...